Search
Selected: U

Use of 4-androstenediol to increase testosterone levels in human

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 4-cholesten-3-one as an anti-obesity agent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 5-alpha-androst-1-en-3,17-dione to increase the level...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 5alpha-androstanediol or 5alpha-androstanedione to...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of 7 &agr;-substituted steroid to treat...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of a pregnane derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of a stanol fatty acid ester for reducing serum cholesterol

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of agonists of the glucocorticosteroid and/or...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of aldosterone antagonists to inhibit myocardial fibrosis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of amino acid precursors for the treatment of addictions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of an aromatase inhibitor in the treatment of decreased andr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of an aromatase inhibitor in the treatment of decreased...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of an H1 antagonist and a safe steroid to treat eye...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of androgen therapy in fibromyalgia and chronic fatigue synd

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of angiostatic steroids in photodynamic therapy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.